The Boehringer Ingelheim Foundation honours particularly outstanding scientific achievements with its science awards. Endowed with 100,000 euros, the Heinrich Wieland Prize honours distinguished scientists from around the world for their groundbreaking research on biologically active molecules and systems in the fields of chemistry, biochemistry, and physiology, as well as their clinical importance. As of 2022, five of the Prize’s laureates have subsequently received the Nobel Prize.
The Foundation awards the Boehringer Ingelheim Prize to excellent and advanced early-career scientists at the University Medical Center of the University of Mainz. It has been presented annually since 1969 for excellence in clinical as well as theoretical medicine, and is endowed with a total of 30,000 euros in prize money.
Each year, the Foundation awards four PhD student prizes at the University of Mainz in recognition of particularly excellent dissertations or theses in biology, medicine, chemistry, and pharmacy.
2022 Heinrich Wieland Prize.
Professor Xiaowei Zhuang of Harvard University in Cambridge, USA, received the 2022 Heinrich Wieland Prize for developing ground-breaking single-molecule and super-resolution imaging methods and applying these to make seminal discoveries in cell biology and neurobiology. She was presented with the 100,000 euro prize during a festive award ceremony following a scientific symposium at Nymphenburg Palace in Munich, Germany, on 6 October 2022.
2021 Boehringer Ingelheim Prize.
Dr Michael Kühn receives the Boehringer Ingelheim Prize for clinical medicine for showing that combining two specific drugs is better for treating a common form of leukemia.
Dr Sabine Muth is awarded the Boehringer Ingelheim Prize for theoretical medicine for her discovery of a pathway gut bacteria use to activate the immune system.
The results of both awardees are of high clinical relevance as they allow to find better treatments.